Inducible T‐cell costimulatory ligand (ICOSLG) expression was found to be increased in GBM tissues and closely linked to poor prognosis in GBM patients by bioinformatics analysis and analysis of GBM tissue microarray assays. This evidence concerns the gene ICOSLG and glioblastoma.